Veraxa Biotech: director Christoph Ziegler bought 30,000 shares

What happened Ziegler Christoph Samuel, a director, bought 30,000 shares of Veraxa Biotech at $1.09 per share on Oct 20, 2026, for a total of $32,700, as reported on the Form 4 filed Oct 21, 2026.

Key details

• Transaction date and price: Oct 20, 2026 — purchase of 30,000 shares at $1.09 per share (code P).
• Total value reported: $32,700.
• Shares owned after the transaction: the filing does not state shares owned following the transaction.
• Footnotes or plans: the filing does not indicate a 10b5-1 plan, tax withholding, or other footnotes.
• Filing date: Form 4 filed on Oct 21, 2026.

Why it may matter

• The filing reports a direct purchase (code P) by a company director.
• A filing does not show why the insider traded or why the company acted.